What are the red flags for Hematuria (presence of blood in urine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Red flags for hematuria include gross hematuria, hematuria with pain, age over 35 years, smoking history, occupational exposure to chemicals, history of pelvic irradiation, and recent urologic procedures, which warrant urgent evaluation due to the association with urological malignancies. These factors are identified as high-risk characteristics that necessitate prompt referral to urology for further investigation, including cystoscopy and upper tract imaging 1. The presence of these red flags indicates a potential for serious underlying conditions, such as bladder or kidney cancer, where early detection significantly improves outcomes.

Key red flags for hematuria are:

  • Gross hematuria (visible blood in urine)
  • Hematuria with pain
  • Age over 35 years
  • Smoking history
  • Occupational exposure to chemicals or dyes
  • History of pelvic irradiation
  • Recent urologic procedures
  • Persistent hematuria despite treatment of initial causes
  • Hematuria with clots
  • Hematuria with constitutional symptoms (weight loss, fatigue)
  • Hematuria in the setting of anticoagulant therapy or bleeding disorders

When these red flags are present, prompt referral to urology is recommended with consideration of cystoscopy and upper tract imaging 1. Even microscopic hematuria should not be dismissed, especially when persistent or accompanied by these red flags, as it may be the earliest sign of serious urological disease 1. The evaluation of hematuria should be pursued even if the patient is receiving antiplatelet or anticoagulant therapy 1.

It is essential to consider the patient's overall clinical presentation and risk factors when evaluating hematuria, rather than relying solely on the presence or absence of blood in the urine. By prioritizing the evaluation of high-risk patients and promptly referring them to urology, clinicians can improve outcomes and reduce the morbidity and mortality associated with urological malignancies.

From the Research

Hematuria Red Flags

  • Hematuria is a common condition that can be classified as either gross or microscopic, and it warrants a thorough history and physical to determine potential causes and assess risk factors for malignancy 2
  • Red flags for hematuria include painless gross hematuria (PGH) and asymptomatic microhematuria (AMH), which can indicate a higher risk of urologic malignancy 3
  • Patients with PGH are more likely to undergo urologic referral and cystoscopy, and have a higher rate of bladder neoplasms detection compared to those with AMH 3
  • The presence of red flags, such as hematuria, can indicate a possible serious underlying condition, and evaluation of these red flags is crucial in primary care to minimize the risk of missing serious diseases 4
  • Chronic kidney disease (CKD) is also a risk factor for kidney or urothelial malignancy, and patients with CKD should be considered for evaluation for the presence and etiology of hematuria 5

Evaluation of Hematuria

  • A focused history and physical, including laboratory studies and diagnostic imaging, is essential in evaluating patients with hematuria 6
  • The cause of hematuria can originate in the genitourinary tract, and patients can be discharged with close outpatient follow-up if they remain stable 6
  • However, delays in evaluation for hematuria can occur, and many of these delays are preventable with interventions such as EHR-based tracking systems or reformed scheduling practices 3

Risk Factors for Malignancy

  • The risk of malignancy with gross hematuria is greater than 10%, and prompt urologic referral is recommended 2
  • CKD is associated with a higher risk of kidney cancer and urothelial carcinoma, and patients with CKD should be considered for evaluation for the presence and etiology of hematuria 5
  • The presence of red flags, such as PGH or AMH, can indicate a higher risk of urologic malignancy, and patients with these red flags should be evaluated promptly 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hematuria.

Primary care, 2019

Research

Evaluation of red flags minimizes missing serious diseases in primary care.

Journal of family medicine and primary care, 2018

Research

Chronic kidney disease and risk of kidney or urothelial malignancy: systematic review and meta-analysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Research

The Approach to the Patient with Hematuria.

Emergency medicine clinics of North America, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.